Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8436
Reference
Drug Alert 17/2025
Name
Drug Alert Class 2 – No 17 2025 – Class 2 medicines recall – action within 48 hours – Recordiati Industria Chimica E Farmaceutica S.P.A – Lercanidipine HCl 20mg tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Medicines Recall
Description
Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to the batch of Lercanidipine HCl 20mg Tablets listed in the table above. The packs of 20mg tablets are incorrectly labelled as 10mg on some sides of the product carton. The correct strength (20mg) is printed on the top of the carton and on the blister strips. Recordati Pharmaceuticals Limited is initiating a recall of the specified batch as a precautionary measure.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2025-04-17 15:28:42
Click to go back to homepage